Commensal Microbiome Breakthrough: "Harmless" Gut Bacteria Found to Actively Manipulate Human Immune Signaling via Micro-Injection Systems

Scientists discover that harmless gut bacteria use microscopic syringes to inject proteins into human cells, actively reshaping immune responses and metabolic health.

By: AXL Media

Published: Mar 27, 2026, 12:00 PM EDT

Source: Information for this report was sourced from ScienceDaily and Helmholtz Munich.

Beyond Passive Residents: The Active Microbiome

For decades, the billions of bacteria residing in the human digestive tract were viewed largely as passive bystanders or indirect metabolic contributors. However, new research published in Nature Microbiology fundamentally shifts this paradigm. A global team of scientists has demonstrated that even "friendly" or commensal bacteria possess the specialized machinery to engage in direct, physical intervention with human cellular biology. By injecting specific proteins into the host, these microbes can bypass traditional chemical signaling to exert immediate control over the body's internal defense mechanisms.

The Discovery of Commensal Type III Secretion Systems

The most striking finding of the study involves the identification of type III secretion systems (T3SS) in non-pathogenic bacteria. Previously, these syringe-like structures were considered the exclusive tools of virulent pathogens such as Salmonella and Shigella, used to hijack host cells during infection. Prof. Pascal Falter-Braun, Director of the Institute for Network Biology at Helmholtz Munich, notes that this discovery proves commensal bacteria are not just "passive residents" but active participants in human physiology. The presence of these injection systems in healthy gut environments suggests a sophisticated, ongoing dialogue between the microbiome and the host that has been overlooked by previous genomic surveys.

Mapping the Effector-Host Interactome

To understand the impact of these bacterial injections, researchers mapped over 1,000 specific interactions between bacterial "effector" proteins and human proteins. The resulting network revealed that gut bacteria specifically target human pathways involved in immune regulation and metabolism. Systematic analysis confirmed that these injected proteins influence NF-κB signaling and cytokine responses—the primary chemical messengers of the immune system. By manipulating these signals, bacteria can either dampen or heighten the host's inflammatory response, effectively "tuning" the immune system from the inside out.